company background image
300636 logo

Jiangxi Synergy Pharmaceutical SZSE:300636 Stock Report

Last Price

CN¥8.49

Market Cap

CN¥3.5b

7D

-3.6%

1Y

-25.3%

Updated

09 Aug, 2024

Data

Company Financials +

Jiangxi Synergy Pharmaceutical Co., Ltd.

SZSE:300636 Stock Report

Market Cap: CN¥3.5b

300636 Stock Overview

Manufactures and sells APIs worldwide.

300636 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth5/6
Past Performance4/6
Financial Health4/6
Dividends1/6

Rewards

Risk Analysis

No risks detected for 300636 from our risk checks.

Jiangxi Synergy Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Jiangxi Synergy Pharmaceutical
Historical stock prices
Current Share PriceCN¥8.49
52 Week HighCN¥12.05
52 Week LowCN¥5.76
Beta-0.088
11 Month Change-9.39%
3 Month Change-21.39%
1 Year Change-25.26%
33 Year Change-0.66%
5 Year Change54.29%
Change since IPO56.44%

Recent News & Updates

Is Jiangxi Synergy Pharmaceutical (SZSE:300636) A Risky Investment?

Jun 28
Is Jiangxi Synergy Pharmaceutical (SZSE:300636) A Risky Investment?

Jiangxi Synergy Pharmaceutical's (SZSE:300636) Profits Appear To Have Quality Issues

May 01
Jiangxi Synergy Pharmaceutical's (SZSE:300636) Profits Appear To Have Quality Issues

Jiangxi Synergy Pharmaceutical Co., Ltd.'s (SZSE:300636) 41% Share Price Surge Not Quite Adding Up

Apr 27
Jiangxi Synergy Pharmaceutical Co., Ltd.'s (SZSE:300636) 41% Share Price Surge Not Quite Adding Up

Recent updates

Is Jiangxi Synergy Pharmaceutical (SZSE:300636) A Risky Investment?

Jun 28
Is Jiangxi Synergy Pharmaceutical (SZSE:300636) A Risky Investment?

Jiangxi Synergy Pharmaceutical's (SZSE:300636) Profits Appear To Have Quality Issues

May 01
Jiangxi Synergy Pharmaceutical's (SZSE:300636) Profits Appear To Have Quality Issues

Jiangxi Synergy Pharmaceutical Co., Ltd.'s (SZSE:300636) 41% Share Price Surge Not Quite Adding Up

Apr 27
Jiangxi Synergy Pharmaceutical Co., Ltd.'s (SZSE:300636) 41% Share Price Surge Not Quite Adding Up

Shareholder Returns

300636CN PharmaceuticalsCN Market
7D-3.6%2.2%-2.1%
1Y-25.3%-10.9%-20.8%

Return vs Industry: 300636 underperformed the CN Pharmaceuticals industry which returned -10.9% over the past year.

Return vs Market: 300636 underperformed the CN Market which returned -20.8% over the past year.

Price Volatility

Is 300636's price volatile compared to industry and market?
300636 volatility
300636 Average Weekly Movement6.0%
Pharmaceuticals Industry Average Movement5.2%
Market Average Movement5.7%
10% most volatile stocks in CN Market9.0%
10% least volatile stocks in CN Market3.8%

Stable Share Price: 300636's share price has been volatile over the past 3 months.

Volatility Over Time: 300636's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20041,362Zhengwei Pangwww.jxsynergy.com

Jiangxi Synergy Pharmaceutical Co., Ltd. manufactures and sells APIs worldwide. It offers raw materials, pharmaceutical intermediates, and fine chemicals. Jiangxi Synergy Pharmaceutical Co., Ltd.

Jiangxi Synergy Pharmaceutical Co., Ltd. Fundamentals Summary

How do Jiangxi Synergy Pharmaceutical's earnings and revenue compare to its market cap?
300636 fundamental statistics
Market capCN¥3.55b
Earnings (TTM)CN¥116.45m
Revenue (TTM)CN¥707.85m

30.5x

P/E Ratio

5.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300636 income statement (TTM)
RevenueCN¥707.85m
Cost of RevenueCN¥491.01m
Gross ProfitCN¥216.83m
Other ExpensesCN¥100.38m
EarningsCN¥116.45m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 29, 2024

Earnings per share (EPS)0.28
Gross Margin30.63%
Net Profit Margin16.45%
Debt/Equity Ratio40.4%

How did 300636 perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

14%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.